Deborah Birx enters new phase as biotech CEO; Verastem chief announces his retirement
→ After entering the public consciousness with the White House Coronavirus Task Force and embarking on a subsequent book tour, Deborah Birx has replaced Brian Varnum as CEO of Armata Pharmaceuticals, a California biotech developing bacteriophages. Concurrent with Birx’s appointment, Armata also picked up $25 million in funding through a subsidiary of Innoviva, where Birx had a seat on the board of directors before joining Armata. Birx was a mainstay with then-NIAID Director Anthony Fauci in White House press briefings at the height of the Covid-19 pandemic.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.